Clinical Trial Update: Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating bevacizumab with irinotecan or with temozolomide plus radiotherapy for glioblastoma multiforme has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Bevacizumab (bevacizumab)
• Irinotecan (Irinotecan)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Ulrik Lassen | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED